A Combinatorial Role of Angiopoietin-1 and Orphan Receptor TIE1 Pathways in Establishing Vascular Polarity during Angiogenesis  Siobhan Loughna, Thomas.

Slides:



Advertisements
Similar presentations
Cardiovascular system Embryology
Advertisements

Development of the Circulatory System
Blood Vessels Arteries carry blood away from heart Ventral aorta
DEVELOPMENT OF THE CIRCULATORY SYSTEM
Development of the Veins
Major Veins of the body.
Cardiovascular Development. The first three weeks By the beginning of the third week, blood vessel formation begins in the tissue surrounding the yolk.
Dr Rania Gabr.  Describe the formation of the aortic arches.  Enlist the derivatives of aortic arches.  Discuss the development of venous system of.
Early development of heart & vessels A,Dorsal view of embryo (about 18 days). B,C, T.S and L.S. showing relationship of angioblastic cords in cardiogenic.
L58: Development of venous system DR. Rehan.  Describe formation of vitelline veins.  Describe formation of umblical veins.  Describe formation of.
Dr Rania Gabr.  Describe the formation of the aortic arches.  Enlist the derivatives of aortic arches.  Discuss the development of venous system of.
Development of the AORTIC ARCHES
VEINS ASSOCIATED WITH HEART
Cardiovascular Development:
Chapter 18: Anatomy of the Blood Vessels
Jeffrey T Wigle, Guillermo Oliver  Cell 
THE VEINS OF THE BODY Dr. Nabil Khouri.
What LAYER of tissue is this?
Portal hepatic vein. Foetal circulation
The “Broken Ring” Sign in Magnetic Resonance Imaging of Partial Anomalous Pulmonary Venous Connection to the Superior Vena Cava  PAUL R. JULSRUD, M.D.,
Genetic Specification of Axonal Arbors
Volume 21, Issue 10, Pages (October 2014)
The Cardiovascular System
F. Gibson, A. Bodenham  British Journal of Anaesthesia 
CD34 Expression Patterns During Early Mouse Development Are Related to Modes of Blood Vessel Formation and Reveal Additional Sites of Hematopoiesis by.
Implication of MEK1 and MEK2 in the establishment of the blood–placenta barrier during placentogenesis in mouse  Jean Charron, Vickram Bissonauth, Valérie.
Phenotypes of GATA‐1.05/Y germline mutant embryos expressing wild‐type or mutant GATA‐1 transgenes. Phenotypes of GATA‐1.05/Y germline mutant embryos expressing.
Volume 10, Issue 1, Pages (January 2006)
Central venous catheter failure is induced by injury and can be prevented by stabilizing the catheter tip  Ted R. Kohler, MD, Thomas R. Kirkman, BS  Journal.
Tony DeFalco, Nicole Camara, Stéphanie Le Bras, Mark Van Doren 
Jeffrey T Wigle, Guillermo Oliver  Cell 
Transcriptional Control of Endothelial Cell Development
An in vivo chemical library screen in Xenopus tadpoles reveals novel pathways involved in angiogenesis and lymphangiogenesis by Roland E. Kälin, Nadja.
Martin Gering, Roger Patient  Developmental Cell 
Volume 6, Issue 5, Pages (May 2004)
Distinct Origins of Adult and Embryonic Blood in Xenopus
Smoothened Mutants Reveal Redundant Roles for Shh and Ihh Signaling Including Regulation of L/R Asymmetry by the Mouse Node  Xiaoyan M. Zhang, Miguel.
Volume 33, Issue 4, Pages (May 2015)
Internal jugular vein Common carotid artery External jugular vein
Volume 11, Issue 1, Pages (July 2006)
Topography of cardiac ganglia in the adult human heart
Volume 8, Issue 4, Pages (April 2005)
Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4  Hai U Wang, Zhou-Feng.
Volume 6, Issue 8, Pages (August 1996)
Victor Hatini, Stephen DiNardo  Molecular Cell 
Volume 94, Issue 3, Pages (August 1998)
BMP4 Plays a Key Role in Left–Right Patterning in Chick Embryos by Maintaining Sonic Hedgehog Asymmetry  Anne-Hélène Monsoro-Burq, Nicole M. Le Douarin 
Volume 8, Issue 1, Pages (July 2014)
Sonic hedgehog and vascular endothelial growth factor Act Upstream of the Notch Pathway during Arterial Endothelial Differentiation  Nathan D. Lawson,
Volume 23, Issue 2, Pages (August 2012)
Volume 154, Issue 3, Pages e73-e76 (September 2018)
Volume 17, Issue 9, Pages (November 2016)
Volume 18, Issue 4, Pages (April 2010)
Male-specific cell migration into the developing gonad
Artery/Vein Specification Is Governed by Opposing Phosphatidylinositol-3 Kinase and MAP Kinase/ERK Signaling  Charles C. Hong, Quinn P. Peterson, Ji-Young.
Volume 94, Issue 3, Pages (August 1998)
Volume 94, Issue 3, Pages (August 1998)
Development of Blood Vessels
Volume 25, Issue 2, Pages (April 2013)
Retroaortic innominate vein with coarctation of the aorta: surgical repair and embryology review  Igor E Konstantinov, MD, Glen S Van Arsdell, MD, Stacy.
Pharyngeal arch patterning in the absence of neural crest
Defective yolk sac vascularization in RapGEF2−/− mice.
Shirin Lalezari, MD, Edris A. F. Mahtab, PhD, Margot M
Symmetrical Mutant Phenotypes of the Receptor EphB4 and Its Specific Transmembrane Ligand ephrin-B2 in Cardiovascular Development  Sebastian S Gerety,
Volume 94, Issue 3, Pages (August 1998)
A Bmp/Admp Regulatory Circuit Controls Maintenance and Regeneration of Dorsal- Ventral Polarity in Planarians  Michael A. Gaviño, Peter W. Reddien  Current.
The Molecular Characterization of the Fetal Stem Cell Marker AA4
Gene Amplification as a Developmental Strategy
The Anterior-Posterior Axis Emerges Respecting the Morphology of the Mouse Embryo that Changes and Aligns with the Uterus before Gastrulation  Daniel.
Diagnostic criteria for penetrating atheromatous ulcer of the thoracic aorta  Shigeki Kimura, MD, Makoto Noda, MD, Michio Usui, MD, Mitsuaki Isobe, MD 
Presentation transcript:

A Combinatorial Role of Angiopoietin-1 and Orphan Receptor TIE1 Pathways in Establishing Vascular Polarity during Angiogenesis  Siobhan Loughna, Thomas N Sato  Molecular Cell  Volume 7, Issue 1, Pages 233-239 (January 2001) DOI: 10.1016/S1097-2765(01)00171-X

Figure 1 Polarized Branching and Left–Right Asymmetry in Vascular Network Formation (A) Three-dimensional schematic diagram of a vessel and its branches. Vessels can branch out from any point in any direction in a polarized manner. (B) Schematic diagram of the principal vessels of the embryonic venous system. The vasculature shows left–right symmetry early on in development but with increasing right-sided dominance and vessels either undergoing regression or enlargement; the venous system shows increasing left–right asymmetry as development proceeds. The umbilicovitelline system forms the vitelline veins, umbilical veins, ductus venosus, and hepatoportal system. The cardinal veins form the rest of the venous system (modified from Bannister et al. 1995). Polarized vessel branching establishes this asymmetric vascular network. ACV, anterior cardinal vein; AV, azygos vein; CCV, common cardinal vein; CIV, common iliac veins; DV, ductus venosus; HV, hemizygous vein; HpV, hepatic vein; IJV, internal jugular vein; IPC, interpostcardinal; ISC, intersubcardinal; IVC, inferior vena cava; LGV, left gonadal vein; LRV, left renal vein; LSV, left suprarenal vein; PCV, posterior cardinal vein; PV, portal vein; S, subclavian; SCV, subcardinal vein; SupCV, supracardinal vein; SIV, superior intercostal vein, SV; sinus venosus; SVC, superior vena cave; UV, umbilical vein; and VV, vitelline vein. Molecular Cell 2001 7, 233-239DOI: (10.1016/S1097-2765(01)00171-X)

Figure 2 Polarized Expression of Ang-1 in the Atrium and Sinus Venosus at E9.5 (A) Schematic diagram of the heart and connecting major vessels at E9.5. The inflow portion of the heart is the caudally located sinus venosus. The left and right horns of the sinus venosus connect to the developing systemic venous circulation via the left and right common cardinal veins, respectively. The anterior cardinal veins, which drain cranial regions, and the posterior cardinal veins, which drain caudal regions, both connect to the common cardinal veins. Further connections to the sinus venosus are the vitelline veins from the yolk sac and umbilical veins from the placenta (modified from Edwards 1998). (B and C) In situ hybridization whole-mount (B) and section (C) of an E8.5 embryo. Ang-1 is expressed symmetrically to the sinus venosus of the heart (yellow arrowheads). (D–G) In situ hybridization on tissue sections of an E9.5 embryo. Ang-1 is expressed in the atrium (D) and sinus venosus (E), except to their ventral left walls (yellow arrows). Both TIE1 (F) and TIE2 (G) are expressed uniformly in the endothelial layer of sinus venosus. LA, left atrium; RA, right atrium; LHS SVH, left-hand side sinus venosus horn; and RHS SVH, right-hand side sinus venosus horn. The scale bar is 100 μm. Molecular Cell 2001 7, 233-239DOI: (10.1016/S1097-2765(01)00171-X)

Figure 3 Requirement of Ang-1 and TIE1 Specifically for Normal Right-Side Venous Formation at E9.5 (A) Ang-1 is an activating ligand for the TIE2 receptor, whereas Ang-2 is an antagonist for this pathway. Tie1 is an orphan receptor. (B) Whole embryos immunostained with a panendothelial marker, CD31. A distinctive normal RHS anterior cardinal vein can be seen in all genotypes (outlined with yellow dotted line) except Ang-1−/− TIE1−/−, where no continuous vessel lumen could be detected. Instead, a network of small disorganized vessels is detected (red arrows). On the LHS, all genotypes have a normal anterior cardinal vein (yellow dotted line). This was confirmed on sectioning with analysis using differential interference contrast (DIC) optics. A normal anterior cardinal vein (ACV) and posterior cardinal vein (PCV) can be seen for all genotypes on the left side and right side (yellow arrows) except for Ang-1−/− TIE1−/−, where both of these vessels are abnormal specifically on the RHS (red arrows). Three to ten embryos of each genotype were analyzed, each of 20–25 somites. The scale bar is 100 μm. (C) High magnification of CD31 immunostained Ang-1−/− TIE1−/− sections using DIC optics. Red arrows point to abnormal anterior and posterior cardinal veins on the RHS. Note the cluster of CD31-positive cells and the very small discontinuous lumen. On the LHS, both vessels exhibit normal large and distinctive lumen (yellow arrows). The scale bar is 25 μm. (D) Schematic diagram showing the failure to form the RHS anterior cardinal and posterior cardinal veins in the Ang-1−/− TIE1−/− knockout. Scattered endothelial cells (black dots) were seen, and the only small discontinuous vessel lumens (red) were observed. All other genotypes had normal anterior and posterior cardinal veins on both the RHS and LHS. ACV, anterior cardinal vein; CCV, common cardinal vein; and PCV, posterior cardinal vein. In addition to the presented genotypes, Ang-1−/− TIE2−/−, Ang-2−/− TIE2−/−, and Ang-2−/− TIE1−/− embryos and all the double-heterozygous embryos were also studied, and they exhibit no difference in the RHS and LHS vascular system at E9.5 (data not shown). Molecular Cell 2001 7, 233-239DOI: (10.1016/S1097-2765(01)00171-X)

Figure 4 Ang-1/Tie1 Pathway Is Involved in an Early Phase of the Right-Hand Side Anterior Cardinal Vein Formation Whole embryos immunostained with a panendothelial marker, CD31 (A, B, C, G, and H). Sections of the wild-type embryos shown in (A)–(C) analyzed using DIC optics (D–F). Although difficult to detect in the whole wild-type E8.5 embryo (A), the primitive anterior cardinal vein can be seen as a very small indistinct lumen on the right side on sections (yellow arrowhead), whereas a lumen could not yet be detected on the left side (D). By E9.0 in a wild-type embryo, the anterior cardinal vein can be seen in the whole embryo (yellow dotted line) (B) and on sections (yellow arrowheads) (E). In a E9.5 wild-type embryo, the anterior cardinal vein is a distinct large vessel that is clearly detected in both the whole embryo (C) and on sections (yellow arrowheads) (F). An abnormal anterior cardinal vein is seen on the right side of an E9.0 Ang-1−/−TIE1−/− embryo (G). The vessel appears tortuous and thinner than a wild-type control (H). Anterior cardinal vein on the left-hand side of an E9.0 Ang-1−/− TIE1−/− embryo was normal (data not shown). Three embryos of each genotype were analyzed. The scale bar is 100 μm. DA, dorsal aorta; LHS SVH, left-hand side sinus venosus horn; and RHS SVH, right-hand side sinus venosus horn. Molecular Cell 2001 7, 233-239DOI: (10.1016/S1097-2765(01)00171-X)